Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)
scientific article published on 01 May 2018
Author/s
author: Bartosz Pula, Bozena Katarzyna Budziszewska, Agnieszka Szymczyk, Krzysztof Warzocha, Krzysztof Jamroziak, Anna Waszczuk-Gajda, Lidia Gil, Ewa Lech-Marańda, Elżbieta Iskierka-Jażdżewska, Monika Długosz-Danecka, Daria Zawirska, Justyna Rybka, Edyta Subocz
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.